Literature DB >> 10398682

Crystal structure of the conserved core of the herpes simplex virus transcriptional regulatory protein VP16.

Y Liu1, W Gong, C C Huang, W Herr, X Cheng.   

Abstract

On infection, the herpes simplex virus (HSV) virion protein VP16 (Vmw65; alphaTIF) forms a transcriptional regulatory complex-the VP16-induced complex-with two cellular proteins, HCF and Oct-1, on VP16-responsive cis-regulatory elements in HSV immediate-early promoters called TAATGARAT. Comparison of different HSV VP16 sequences reveals a conserved core region that is sufficient for VP16-induced complex formation. The crystal structure of the VP16 core has been determined at 2.1 A resolution. The results reveal a novel, seat-like protein structure. Together with the activity of mutant VP16 proteins, the structure of free VP16 suggests that it contains (1) a disordered carboxy-terminal region that associates with HCF, Oct-1, and DNA in the VP16-induced complex, and (2) a structured region involved in virion assembly and possessing a novel DNA-binding surface that differentiates among TAATGARAT VP16-response elements.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10398682      PMCID: PMC316849          DOI: 10.1101/gad.13.13.1692

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  51 in total

1.  Structural studies of the acidic transactivation domain of the Vmw65 protein of herpes simplex virus using 1H NMR.

Authors:  P O'Hare; G Williams
Journal:  Biochemistry       Date:  1992-04-28       Impact factor: 3.162

2.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

3.  Interference with the assembly of a virus-host transcription complex by peptide competition.

Authors:  A Haigh; R Greaves; P O'Hare
Journal:  Nature       Date:  1990-03-15       Impact factor: 49.962

4.  VP16 targets an amino-terminal domain of HCF involved in cell cycle progression.

Authors:  A C Wilson; R N Freiman; H Goto; T Nishimoto; W Herr
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

5.  Improved tools for biological sequence comparison.

Authors:  W R Pearson; D J Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

6.  The cellular C1 factor of the herpes simplex virus enhancer complex is a family of polypeptides.

Authors:  T M Kristie; J L Pomerantz; T C Twomey; S A Parent; P A Sharp
Journal:  J Biol Chem       Date:  1995-03-03       Impact factor: 5.157

7.  Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription.

Authors:  M E Campbell; J W Palfreyman; C M Preston
Journal:  J Mol Biol       Date:  1984-11-25       Impact factor: 5.469

8.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

9.  Structural requirements in the herpes simplex virus type 1 transactivator Vmw65 for interaction with the cellular octamer-binding protein and target TAATGARAT sequences.

Authors:  R F Greaves; P O'Hare
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

10.  Herpes simplex virus VP16 forms a complex with the virion host shutoff protein vhs.

Authors:  C A Smibert; B Popova; P Xiao; J P Capone; J R Smiley
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  25 in total

1.  Differences in determinants required for complex formation and transactivation in related VP16 proteins.

Authors:  M Grapes; P O'Hare
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Herpes simplex virus infections are arrested in Oct-1-deficient cells.

Authors:  Mauricio L Nogueira; Victoria E H Wang; Dean Tantin; Phillip A Sharp; Thomas M Kristie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

3.  Analysis of the interaction between the essential herpes simplex virus 1 tegument proteins VP16 and VP1/2.

Authors:  Stanislava Svobodova; Susanne Bell; Colin M Crump
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  Phosphorylation of the VP16 transcriptional activator protein during herpes simplex virus infection and mutational analysis of putative phosphorylation sites.

Authors:  Søren Ottosen; Francisco J Herrera; James R Doroghazi; Angela Hull; Sheenu Mittal; William S Lane; Steven J Triezenberg
Journal:  Virology       Date:  2005-11-17       Impact factor: 3.616

5.  Mutations in host cell factor 1 separate its role in cell proliferation from recruitment of VP16 and LZIP.

Authors:  S S Mahajan; A C Wilson
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

6.  Crystal structure of the herpesvirus inner tegument protein UL37 supports its essential role in control of viral trafficking.

Authors:  Jared D Pitts; Jenifer Klabis; Alexsia L Richards; Gregory A Smith; Ekaterina E Heldwein
Journal:  J Virol       Date:  2014-03-05       Impact factor: 5.103

7.  DNA recognition by the herpes simplex virus transactivator VP16: a novel DNA-binding structure.

Authors:  R Babb; C C Huang; D J Aufiero; W Herr
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

8.  Sequence and function of canine herpesvirus alpha-transinducing factor and its interaction with an immediate early promoter.

Authors:  Scott G Tyack; Michael J Studdert; Michael A Johnson
Journal:  Virus Genes       Date:  2006-12       Impact factor: 2.332

9.  The neuronal host cell factor-binding protein Zhangfei inhibits herpes simplex virus replication.

Authors:  Oksana Akhova; Matthew Bainbridge; Vikram Misra
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

10.  The major determinant for addition of tegument protein pUL48 (VP16) to capsids in herpes simplex virus type 1 is the presence of the major tegument protein pUL36 (VP1/2).

Authors:  Debbie H Ko; Anthony L Cunningham; Russell J Diefenbach
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.